Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-20

Clinical Trial Update: FACT Biomarker Subgroup Analysis

View source ↗

Summary

The FACT trial's biomarker subgroup analysis in preeclampsia has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Pre-Eclampsia | Status: COMPLETED | Results posted: 2024-05-20